M Stock Overview
A private healthcare provider, offers healthcare services in Bucharest, Cluj, Braila, Timisoara, Iasi, Galati, Ploiesti, Constanta, and Targu Mures.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Med Life S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | RON4.71 |
| 52 Week High | RON4.88 |
| 52 Week Low | RON3.83 |
| Beta | 0.67 |
| 1 Month Change | 14.34% |
| 3 Month Change | 18.07% |
| 1 Year Change | 4.67% |
| 3 Year Change | 38.89% |
| 5 Year Change | 270.23% |
| Change since IPO | 334.31% |
Recent News & Updates
Recent updates
Is Med Life (BVB:M) A Risky Investment?
Apr 05
Returns On Capital Signal Tricky Times Ahead For Med Life (BVB:M)
Jul 05Is Med Life (BVB:M) A Risky Investment?
Jan 06Med Life (BVB:M) Hasn't Managed To Accelerate Its Returns
Dec 06We Think Med Life (BVB:M) Is Taking Some Risk With Its Debt
Sep 27Returns Are Gaining Momentum At Med Life (BVB:M)
May 05Is There An Opportunity With Med Life S.A.'s (BVB:M) 49% Undervaluation?
Mar 01Med Life (BVB:M) Shareholders Will Want The ROCE Trajectory To Continue
Jan 22Does Med Life (BVB:M) Have A Healthy Balance Sheet?
Aug 31Med Life's (BVB:M) Returns On Capital Are Heading Higher
Jun 10Here's Why We Think Med Life (BVB:M) Is Well Worth Watching
May 26Is Now An Opportune Moment To Examine Med Life S.A. (BVB:M)?
May 12Is There An Opportunity With Med Life S.A.'s (BVB:M) 24% Undervaluation?
Apr 12Update: Med Life (BVB:M) Stock Gained 98% In The Last Year
Mar 16Should We Be Excited About The Trends Of Returns At Med Life (BVB:M)?
Mar 04Should You Be Impressed By Med Life S.A.'s (BVB:M) ROE?
Feb 20
Med Life (BVB:M) Seems To Use Debt Quite Sensibly
Feb 07Is It Too Late To Consider Buying Med Life S.A. (BVB:M)?
Jan 25Do Med Life's (BVB:M) Earnings Warrant Your Attention?
Jan 08Is Med Life S.A. (BVB:M) Trading At A 22% Discount?
Dec 23Did You Miss Med Life's (BVB:M) 49% Share Price Gain?
Dec 08The Trends At Med Life (BVB:M) That You Should Know About
Nov 24Shareholder Returns
| M | RO Healthcare | RO Market | |
|---|---|---|---|
| 7D | 2.5% | 0.5% | 1.6% |
| 1Y | 4.7% | 0.7% | 29.1% |
Return vs Industry: M exceeded the RO Healthcare industry which returned 0.7% over the past year.
Return vs Market: M underperformed the RO Market which returned 29.1% over the past year.
Price Volatility
| M volatility | |
|---|---|
| M Average Weekly Movement | 3.4% |
| Healthcare Industry Average Movement | 4.9% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in RO Market | 9.2% |
| 10% least volatile stocks in RO Market | 2.4% |
Stable Share Price: M has not had significant price volatility in the past 3 months.
Volatility Over Time: M's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 6,997 | Mihail Marcu | www.medlife.ro |
Med Life S.A., a private healthcare provider, offers healthcare services in Bucharest, Cluj, Braila, Timisoara, Iasi, Galati, Ploiesti, Constanta, and Targu Mures. Its Corporate business line offers health prevention packages to corporate clients, which cover regular check-ups and access to diagnostic services. The company's Clinics business line provides services through hyper clinics for clinical examinations and imaging services, as well as clinics that offer a range of treatments from general practitioner services to specialists, as well as day inpatient services.
Med Life S.A. Fundamentals Summary
| M fundamental statistics | |
|---|---|
| Market cap | RON2.46b |
| Earnings (TTM) | RON10.85m |
| Revenue (TTM) | RON2.34b |
230.3x
P/E Ratio1.1x
P/S RatioIs M overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| M income statement (TTM) | |
|---|---|
| Revenue | RON2.34b |
| Cost of Revenue | RON1.21b |
| Gross Profit | RON1.13b |
| Other Expenses | RON1.12b |
| Earnings | RON10.85m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 30, 2024
| Earnings per share (EPS) | 0.02 |
| Gross Margin | 48.31% |
| Net Profit Margin | 0.46% |
| Debt/Equity Ratio | 231.8% |
How did M perform over the long term?
See historical performance and comparison